People

Anna-Maria Alves

Anna-Maria Alves

Anna-Maria Alves was publicly named by Arkuda Therapeutics as Associate Scientist. She developed progranulin assays and evaluated potential therapies. Her background includes Sanofi-Genzyme and Navitor Pharmaceuticals and an MS in cellular and molecular biology from UMass Amherst. Arkuda affiliation is historical; continued employment or board membership after the2025 asset sale is unverified.

Roles

Arkuda Therapeutics

Associate Scientist (archived company roster; historical, current status unverified)

Current